ArticleJACC. CardioOncology2026

Cardiovascular Adverse Events Following Bispecific T-Cell Redirecting Antibody Therapy.

Eli Grunblatt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.